Key facts
- It has raised $1.6M; the latest was Later Stage VC ($1.2M) in Apr 2026.
- Notable investors include Tech Incubator Program for Startup, CNT Tech, Richardsons Capital, JB Ventures, Temasek Trust.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Injewelme
- ·The full record, as it builds
Funding rounds
No funding rounds for Injewelme are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Injewelme
Developer of AI-powered digital health software designed for preventive care and lifestyle management. The company's platform features gamified health tracking, facial-recognition-based vital-sign monitoring, personalized obesity-care missions for children, and cross-platform accessibility, enabling healthcare providers and parents to support early-stage wellness interventions and behavioral improvements through engaging, data-driven, and non-invasive tools.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2020
- Employees
- 5
- Website
- injewelme.com/
- Ownership
- Privately Held (backing)
Injewelme doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Injewelme shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Injewelme in its N-PORT filings yet. We sweep new filings monthly.